Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, October 2, 2015

Resveratrol Moderates Alzheimer’s Severity

This report makes it much more likely to be able to get enough resveratrol naturally. Only 400 bottles of red wine daily instead of 1000 bottles a day. You do know that the natural form is much better than taking it as a supplement? I'm sure your doctor would agree.

Then there is the resveratrol preconditioning which reduces the impact of a stroke. Your doctor should know the exact amount of bottles of red wine to be consumed daily both as a prevention of ischemic harm and a reduction in Alzheimers. If your doctor doesn't know this, call up the damned hospital president and ask why s/he has such incompetent people in place.  Someone has to light a fire under our stroke medical professionals. With 10 million yearly stroke survivors  all screaming for results from their doctors we may finally get to the tipping point where stroke is talked about with breathless anticipation for research solutions. Not just the lazy press releases.

Resveratrol Moderates Alzheimer’s Severity

Arandomized, placebo-controlled, double-blind, multicenter study has discovered that high doses of resveratrol may be beneficial for fighting Alzheimer’s disease (AD).1 Resveratrol is a member of the stilbene family, which acts as an antifungal molecule in a variety of plant species in response to pathogen attack or under stress conditions such as UV radiation and exposure to heavy metal ions. Over the years, resveratrol has been touted as a possible antidote to Alzheimer’s disease, cancer, diabetes and many other conditions.
In the new report, the first study of resveratrol in people with AD, researchers reported that a purified form of resveratrol—what “purified” means wasn’t clarified*—helped stabilize amyloid-beta40 (Aβ40) levels in the blood and cerebrospinal fluid of those who consumed resveratrol, compared to the placebo group, which saw their Aβ40 levels declined. Deposition of Aβ in the brain is a pathological hallmark of AD. There are two major isoforms of Aβ: Aβ42 and Aβ40. A decrease in Aβ40 is seen in the blood and cerebrospinal fluid as dementia worsens and Alzheimer’s disease progresses. Stabilization is good.
From Blood to Brain
This decline is thought to be a sign that Aβ40 was being taken from their blood and deposited in Alzheimer’s patients’ brains. Those taking resveratrol, however, showed little or no change in Aβ40 levels in their blood.
The study included 119 patients randomly assigned to either high doses of resveratrol (n = 64) or placebo (n = 55). Ranging from age 50 to 90, the mean age for the resveratrol group was 70; the mean age for the placebo group was 73.

A decrease in Aβ40 is seen in
the blood and cerebrospinal fluid as
dementia worsens and Alzheimer’s
disease progresses. Resveratrol
stabilizes blood and cerebral levels.

The resveratrol used in the study was introduced at a dose of 500 mg a day and was increased every 3 months by 500 mg, so that by the end of the 1-year study, subjects were taking 2000 mg a day. The researchers looked at several biomarkers of Alzheimer’s and found that people who took up to 2,000 mg a day during the last quarter year had higher levels of Aβ40 in their spinal fluid than those who took a placebo.
Although accumulation of Aβ40 in the brain is a marker for AD, these same individuals have lower levels of Aβ40 outside of the brain. Thus, the study’s finding suggests that resveratrol could help change the balance from Aβ40 buildup in the brain to circulating protein in the body, where it is less reflective of neurodegeneration.
At the highest dose given in the study (2,000 mg resveratrol per day), you’d have to drink at least 400 bottles of red wine per day to obtain that much resveratrol—but in the study, that amount was represented by four 500 mg capsules per day. Parenthetically, by using a non-natural form of resveratrol, the researchers were granting superior status to extracts or synthetic forms.

The finding suggests that resveratrol
could change the balance from Aβ40
buildup in the brain to circulating
protein in the body, where it is less
reflective of neurodegeneration.

The current study was the largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate AD.
However, this is not the first time that resveratrol has been connected to AD. In fact, the earliest research goes back to 1998, and includes 200 scientific papers involving AD and resveratrol.
During this time there have been many hypotheses, many of which have been tested again and again.

No comments:

Post a Comment